Top Machine Learning Companies in London (273)

Strong Revenue Growth: Revenue rose 31% year over year to NZ$2.75–2.80 billion, alongside 37% AMRR growth and a 23% uplift in average revenue per customer. Customers increased 11% to about 4.92 million, reinforcing top-line momentum.

Healthy Cash Flow: Free cash flow reached NZ$554 million in FY26, increasing from the prior year. Adjusted EBITDA also grew 18% to NZ$757 million, indicating strong cash generation while scaling.

Market Expansion: Growth accelerated in the U.S. (including Melio payments) with continued double‑digit momentum in ANZ and the UK. Net additions of 506,000 in FY26 and a 4.92 million customer base highlight expanding regional reach.

Strong Revenue Growth: Q2 2026 total net revenue rose 4% sequentially to $15.9 billion. Integration of Discover and Brex contributed to higher non‑interest income and broader payments capabilities.

Profitability: Q2 2026 net income reached $3.0 billion, up from $2.2 billion in Q1 2026, alongside a net interest margin of 8.01%. Management also cited strong credit performance, including a $662 million reserve release.

Market Expansion: Acquisition‑driven scale is broadening reach, with the Discover deal (closed May 18, 2025) and Brex (closed April 7, 2026) adding network and corporate card/spend‑management capabilities. Balance‑sheet growth continued in Q2 2026 as period‑end loans rose 2% to $457.2 billion and total assets reached $673.8 billion.

Profitability: FY2026 marked the first full year of GAAP profitability, and Q1 FY2027 delivered a fourth consecutive GAAP‑profitable quarter. Profit guidance and expanding non‑GAAP operating margins indicate continued bottom‑line strength.

Healthy Cash Flow: Free cash flow was $102.7M in FY2026 and $41.2M in Q1 FY2027. Cash and investments of $444M and a $100M share repurchase authorization underscore liquidity to invest while returning capital.

Future-Ready Strategy: Management emphasizes AI‑first Operations Cloud offerings and a new usage‑based package aimed at re‑accelerating growth. Product and packaging moves are positioned to drive longer‑term expansion and retention.

Strong Revenue Growth: Galleri and total revenue have risen consistently, with full-year 2025 up 17% and U.S. Galleri up 26%, followed by Q1–Q2 2026 total revenue gains of 28% and 26% alongside 50% and 35% volume growth. This cadence, including Q4 2025 Galleri revenue up 31%, indicates sustained commercial momentum after the June 2024 spin‑off.

Strategic Partnerships: Channel and platform integrations such as Epic EHR and Quest Diagnostics, plus collaborations like Samsung for Asian commercialization, are expanding access and streamlining ordering. Additional distribution wins (e.g., Priority Health employer plans and digital health channels) reinforce multi‑channel penetration for Galleri.

Investor Backing & Capital Strength: The company reports a substantial cash balance (~$861.6M as of Q2 2026) and closed a $110M equity financing with Samsung, bolstering financial flexibility. Public listing post‑spin‑off further enhances capital‑markets access to fund trials and commercialization.

Strong Revenue Growth: Revenue accelerated to about $1.60B in Q2 2026, up 19% year over year, following 12% growth in Q1 2026 and an 11% increase for full-year 2025. Rising ARPU alongside expanding DAU/MAU supported this top-line momentum.

Healthy Cash Flow: Q2 2026 free cash flow reached roughly $121M and operating cash flow improved to about $176M, both sharply higher year over year. These gains indicate improved operating efficiency even as GAAP net income remains negative.

Diversified Revenue Streams: “Other revenue” driven by subscriptions like Snapchat+ grew ~85% year over year in Q2 2026 (after ~87% in Q1), and Snapchat+ surpassed 25M subscribers by mid‑2026. This diversification is complementing ad recovery and helping sustain growth.

Strong Market Position & Advantage: Repeated Leader placements in Gartner’s DEX Magic Quadrant (2024–2026) and Forrester’s 2024 EUEM Wave indicate durable competitive standing and sustained category momentum. These recognitions coincide with communications citing 1,200–1,500+ customers and 20M+ endpoints, underscoring broad enterprise adoption.

Product Line Growth: New offerings such as Adopt on Infinity (2025) and the Spark personal IT agent (2026), plus integrations like GoTo/Rescue and a government-focused AWS Marketplace listing, expand use cases and routes to market. The 2024 acquisition of AppLearn further broadened capabilities into digital adoption.

Investor Backing & Capital Strength: A late‑2025 majority investment by Vista Equity Partners at an approximately $3B valuation signals strong external confidence and provides resources for scaling. This step-up from the 2021 round supports continued product and go‑to‑market execution.

Resilient & Sustainable Growth: Growth is described as measured and predictable, with signals such as modest headcount expansion, sustained operating scale, and continued momentum rather than volatility.

Innovation-Driven Growth: Recent major releases across IRIS/IRIS for Health/Health Connect and new AI-focused offerings indicate ongoing R&D velocity that broadens capabilities and use cases.

Strong Market Position & Advantage: Repeated industry accolades for Shared Care Records/HIE and regional acute EHRs in 2026 point to durable competitive standing in core healthcare markets.

Strong Revenue Growth: Revenue is on a clear upward trajectory, with estimates rising from 2024 through 2025, leadership guiding to a substantially larger 2026, and a stated path toward $1B by 2028. This momentum is tied to increasing orders, expanding programs, and a growing mix of software and systems.

Investor Backing & Capital Strength: A multi‑billion‑dollar capital package closed in March 2026, including a $1.5B Series G at a $12.7B valuation plus additional preferred equity and a delayed‑draw facility. This financing depth provides runway to scale autonomy software, aircraft programs, and the Aechelon acquisition.

Market Expansion: Operations and sales expanded internationally with new contracts across allies including Romania, Japan, Greece, and Canada, while U.S. traction includes Air Force CCA autonomy selections and a Navy contract to further develop X‑BAT. Over time, these moves broaden geographic reach and platform adoption.

Strong Revenue Growth: Management disclosed 11 consecutive quarters of top-line expansion as of Q2 2026, with guidance indicating continued increases post‑IPO. Observations across filings and coverage describe multi‑quarter momentum rather than a one‑off spike.

Investor Backing & Capital Strength: A completed IPO and a prior minority investment from General Atlantic alongside Blackstone signal institutional confidence and provide balance‑sheet flexibility. Proceeds were used in part to reduce debt, supporting capacity for further expansion.

Innovation-Driven Growth: The Cortex AI platform is presented as a core differentiator driving performance gains across a unified DSP/SSP stack. Product updates and shortened learning cycles are highlighted as catalysts for advertiser and publisher adoption.

Strong Revenue Growth: Revenue accelerated across early 2026, with Q2 performance surpassing guidance and prompting management to raise the full‑year outlook to around $1 billion of revenue and higher adjusted EBITDA. Guidance increases followed multi‑quarter momentum from 2025 into 2026.

Diversified Revenue Streams: Media Technology grew sharply with stronger advertising demand and the Legend acquisition, while expansion into prediction markets adds a new category beyond core betting data. This mix shift broadens exposure beyond a single segment and supports the higher full‑year targets.

Innovation-Driven Growth: New offerings such as GeniusIQ, Moment Engine, and BetVision—alongside price‑led renewals and expanded services in Betting Technology—are identified as key drivers of segment gains. Product momentum in ad tech and data‑rich streaming is contributing meaningfully to growth.

Strong Revenue Growth: Company communications describe substantially accelerated revenue growth in 2024 with “exceptional momentum” continuing into Q1 2025 and performance on track to exceed financial targets. These statements align with concurrent product launches and go-to-market investments.

Product Line Growth: Multiple new offerings and upgrades—such as Accuris Thread (2025), an AI Assistant (2026), AI-powered BOM Intelligence (2026), and Engineering Workbench enhancements—signal sustained investment in the roadmap. This cadence broadens solution scope and supports upsell and cross-sell potential.

Market Expansion: A new global headquarters in Denver and additional offices in the UK, India, Malaysia, and Japan indicate an expanding geographic footprint. Senior commercial hires (e.g., a CRO in 2025 and a Head of Sales, Americas in 2026) further suggest scaling sales capacity.

Strong Revenue Growth: Reported revenue rose from $1.9B in 2024 to $5.1B in 2025, with early‑2026 quarters continuing triple‑digit year‑over‑year increases. These disclosures indicate a steep, ongoing acceleration in scale.

Strategic Partnerships: Multi‑year, multi‑billion‑dollar agreements with Meta, Anthropic, Jane Street, and expanded OpenAI commitments point to durable, large‑scale utilization. A deepened NVIDIA collaboration, including early deployments of GB200/GB300 and plans to accelerate AI “factory” buildouts, supports access to cutting‑edge capacity.

Investor Backing & Capital Strength: Significant financing and market recognition—including a $1.1B Series C, large credit and notes facilities, and inclusion in the Nasdaq‑100—underscore strong capital access. This funding underpins rapid data‑center expansion and GPU procurement.

Investor Backing & Capital Strength: A large Series B of about $130M at roughly a $700M valuation in mid-2024 and an additional 2026 venture event signal strong access to capital and confidence from prominent investors. This financing base supports continued product and go-to-market expansion.

Strong Revenue Growth: Revenue was reported at roughly $13M and profitable by mid-2024 with claims of ~15x growth over the prior 18 months. Subsequent disclosures of 373% year-over-year growth in EMEA from FY25 to FY26 indicate continued momentum.

Market Expansion: Named deployments and expansions in finance and legal, including firm-wide or expanded use at Ropes & Gray and Seyfarth Shaw, point to deepening penetration in high-value niches. Alignment with advanced reasoning models and ongoing platform upgrades further support scaling into production use cases.

Investor Backing & Capital Strength: A $200M Series C in July 2024 at a reported $1B valuation provides material resources for product expansion and scaling. Active hiring across engineering, product, sales, and government affairs aligns with investment-fueled growth plans.

Market Expansion: U.S. Customs and Border Protection executed a formal two-year contract to test the platform in 2025. FedRAMP High authorization in February 2026 reduces procurement friction with federal agencies and regulated customers, positioning the company for broader rollout.

Product Line Growth: The July 2026 acquisition of Cervo AI enables an end-to-end, agentic customs brokerage workflow. Altana states this brings its logistics customer base to “8 of the 10 largest logistics providers,” indicating capability-driven expansion.

Strong Revenue Growth: ARR is described as rising from over $300M in 2025 to over $400M by mid-2026, alongside large-scale telemetry usage that signals expanding adoption. This trajectory indicates sustained top-line expansion through 2026.

Innovation-Driven Growth: AI-led capabilities such as Edwin AI are portrayed as a meaningful driver of bookings with rapid recurring revenue momentum, and the company is advancing an “Autonomous IT” roadmap. Continued AI feature launches through 2026 point to product-led expansion.

Investor Backing & Capital Strength: An $800M financing in late 2024 at around a multi‑billion valuation provides resources to accelerate platform expansion, acquisitions, and entry into new markets. This capital base supports ongoing scaling initiatives.

Strong Revenue Growth: Recent financial results show net trading revenue rising from $2.235B in 2024 to a record $3.12B in 2025, indicating robust top-line momentum. Company disclosures characterize 2024 as a record year and 2025 as a period of strong performance and healthy growth.

Profitability: Net profit reached $968M in 2025 and total equity increased to $2.58B from the prior year, signaling solid earnings and balance-sheet strength. These gains support continued investment in people, technology, and trading capabilities cited by the firm.

Diversified Revenue Streams: Expansion into FX and commodity-derivatives market making from London and the addition of institutional crypto liquidity via the Talos network broaden the firm’s revenue drivers. Geographic build-outs in Hong Kong and New York further underpin multiple businesses across regions.

Market Expansion: 150+ new clients in 2025, growth across EMEA and APAC, and a community surpassing 500 firms by mid-2026 indicate widening geographic and segment reach. Document throughput at scale across 44,000+ funds further supports expanding footprint.

Strategic Partnerships: Integrations with Envestnet | Tamarac and a certified data feed into Bloomberg PORT Enterprise, alongside ecosystem ties with major banks and administrators, embed the platform in core wealth and institutional workflows. Such connections broaden distribution and reinforce stickiness.

Investor Backing & Capital Strength: A $36M Series C led by Goldman Sachs Alternatives in July 2024 and a definitive agreement for Bloomberg to acquire the company in July 2026 signal strong financial support and third‑party validation. These milestones underpin continued investment in product and market expansion.